Friday, April 4, 2025
HomeNews

News

Stepan Company Executes $450 Million Credit Facility Agreement

Stepan Company, announced that it has entered into credit agreement providing for a five-year committed $350 million multi-currency revolving credit facility and a $100...

Tata Chemicals Europe Opens UK’s Largest Carbon Capture Plant

Tata Chemicals Europe opened the UK's first industrial scale carbon capture and usage plant , signalling a key milestone in the race to meet...

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

Biofluidica announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive Next-Generation Liquid Biopsy platform, LiquidScan™ to...

Antios Therapeutics’ ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study

Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing transformative treatments for hepatitis B virus (HBV), announced new data from the Phase 2a clinical...

Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults

Astellas Pharma Inc. announced that the US Food and Drug Administration (FDA) has placed a clinical hold on the FORTIS Phase 1/2 trial following...
0FansLike
0FollowersFollow
spot_img

Hot Topics